AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • February 2nd, 2021 • Boston Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of February 2, 2021, is entered into by and among BOSTON THERAPEUTICS, INC., a Delaware corporation (“Public Company”); BTHE Acquisition Inc., a California corporation and a wholly owned subsidiary of Public Company (the “Merger Sub”); and NANOMIX, INC., a California corporation (“Merger Partner,” and together with Public Company and the Merger Sub, the “Parties”).
DEBT SETTLEMENT AGREEMENT AND RELEASEDebt Settlement Agreement and Release • February 2nd, 2021 • Boston Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS DEBT SETTLEMENT AGREEMENT AND RELEASE (this “Agreement”) is made and entered into as of January 25, 2021 (the “Effective Date”), by and between _____ (the “Creditor”) and Boston Therapeutics, Inc., a Delaware corporation (the "Company").
EXCHANGE AGREEMENTExchange Agreement • February 2nd, 2021 • Boston Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS EXCHANGE AGREEMENT (the “Agreement”) is made as of the ___ day of _____ 2021, by and between, Boston Therapeutics, Inc., a Delaware corporation (the “Company”), and ____________ (the “Holder”).
